Q4 2020 Holdings
Filed 2021-02-16 | 87 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $308.5M | 3,778,262 | 24.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $270.1M | 918,307 | 21.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $148.8M | 1,388,904 | 11.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $93.2M | 2,231,710 | 7.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $86.3M | 3,448,030 | 6.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $82.8M | 960,400 | 6.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $53.0M | 216,247 | 4.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $47.5M | 2,711,616 | 3.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $47.3M | 580,746 | 3.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $33.3M | 554,962 | 2.6% |
| Avita Therapeutics Inc(RCEL) | COM | 05380C102 | $31.7M | 1,707,386 | 2.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $22.7M | 3,514,100 | 1.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $20.1M | 500,000 | 1.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.2M | 1,378,319 | 1.3% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $16.4M | 2,054,131 | 1.3% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.1M | 12,629,737 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $476.1K | 20,620,490 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $373.4K | 2,667,451 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $302.4K | 3,425,455 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $294.5K | 5,619,914 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $253.3K | 4,437,968 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $220.1K | 5,263,309 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $216.3K | 6,758,794 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $178.9K | 2,925,711 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $176.5K | 11,724,726 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $168.7K | 2,720,489 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $166.4K | 2,686,234 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $152.3K | 3,993,399 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $144.4K | 3,309,194 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $140.6K | 2,896,589 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $134.7K | 6,863,070 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $133.3K | 2,288,846 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $125.5K | 2,416,406 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $102.6K | 9,450,305 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $100.5K | 1,675,036 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $96.4K | 1,984,690 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $96.3K | 2,123,492 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $94.1K | 815,681 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $93.6K | 2,846,125 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $90.8K | 2,647,696 | 0.0% |
| Allovir Inc | COM | 019818103 | $89.4K | 2,325,595 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $87.6K | 2,832,888 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $79.8K | 383,093 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $78.8K | 224,639 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $78.5K | 244,332 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $77.0K | 3,388,376 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $76.8K | 443,909 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $67.9K | 10,528,179 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $66.2K | 4,537,400 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $59.9K | 2,322,557 | 0.0% |